Literature DB >> 20853900

Synthesis and evaluation of selected key methyl ether derivatives of vancomycin aglycon.

Christine M Crane1, Joshua G Pierce, Siegfried S F Leung, Julian Tirado-Rives, William L Jorgensen, Dale L Boger.   

Abstract

A select series of methyl ether derivatives of vancomcyin aglycon were prepared and examined for antimicrobial activity against vancomycin-sensitive Staphylococcus aureus and vancomycin-resistant Enterococci faecalis as well as their binding affinity for D-Ala-D-Ala and D-Ala-D-Lac. The intent of the study was to elucidate the role selected key methyl groups may play in the improvement of the in vitro antimicrobial profile of the tetra methyl ether derivative of vancomycin aglycon against vancomycin-resistant Enterococci faecalis previously reported. In these studies, methodology for selective derivatization of the A-, B-, and D-ring was developed that defines the relative reactivity of the four phenols of vancomycin aglycon, providing a foundation for future efforts for site-directed modification of the vancomycin aglycon core.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20853900      PMCID: PMC2981068          DOI: 10.1021/jm100946e

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  43 in total

1.  Partitioning the loss in vancomycin binding affinity for D-Ala-D-Lac into lost H-bond and repulsive lone pair contributions.

Authors:  Casey C McComas; Brendan M Crowley; Dale L Boger
Journal:  J Am Chem Soc       Date:  2003-08-06       Impact factor: 15.419

2.  A new and improved method for deglycosidation of glycopeptide antibiotics exemplified with vancomycin, ristocetin, and ramoplanin.

Authors:  Jutta Wanner; Datong Tang; Casey C McComas; Brendan M Crowley; Wanlong Jiang; Jason Moss; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2003-03-24       Impact factor: 2.823

Review 3.  Vancomycin assembly: nature's way.

Authors:  Brian K Hubbard; Christopher T Walsh
Journal:  Angew Chem Int Ed Engl       Date:  2003-02-17       Impact factor: 15.336

Review 4.  Glycopeptide antibiotics: from conventional molecules to new derivatives.

Authors:  Françoise Van Bambeke; Yves Van Laethem; Patrice Courvalin; Paul M Tulkens
Journal:  Drugs       Date:  2004       Impact factor: 9.546

5.  Total synthesis of the ristocetin aglycon.

Authors:  Brendan M Crowley; Yoshiki Mori; Casey C McComas; Datong Tang; Dale L Boger
Journal:  J Am Chem Soc       Date:  2004-04-07       Impact factor: 15.419

6.  Specificity of combination between mucopeptide precursors and vancomycin or ristocetin.

Authors:  H R Perkins
Journal:  Biochem J       Date:  1969-01       Impact factor: 3.857

7.  Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages.

Authors:  Cristina Seral; Françoise Van Bambeke; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

8.  The specificity of combination between ristocetins and peptides related to bacterial cell wall mucopeptide precursors.

Authors:  M Nieto; H R Perkins
Journal:  Biochem J       Date:  1971-10       Impact factor: 3.857

9.  Synthesis and evaluation of methyl ether derivatives of the vancomycin, teicoplanin, and ristocetin aglycon methyl esters.

Authors:  Casey C McComas; Brendan M Crowley; Inkyu Hwang; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2003-09-01       Impact factor: 2.823

10.  Physicochemical properties of vancomycin and iodovancomycin and their complexes with diacetyl-L-lysyl-D-alanyl-D-alanine.

Authors:  M Nieto; H R Perkins
Journal:  Biochem J       Date:  1971-08       Impact factor: 3.857

View more
  8 in total

1.  Investigation into the functional impact of the vancomycin C-ring aryl chloride.

Authors:  Joseph R Pinchman; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2013-07-04       Impact factor: 2.823

2.  Catalytic site-selective thiocarbonylations and deoxygenations of vancomycin reveal hydroxyl-dependent conformational effects.

Authors:  Brandon S Fowler; Kai M Laemmerhold; Scott J Miller
Journal:  J Am Chem Soc       Date:  2012-05-23       Impact factor: 15.419

3.  Total synthesis of [Ψ[C(═S)NH]Tpg4]vancomycin aglycon, [Ψ[C(═NH)NH]Tpg4]vancomycin aglycon, and related key compounds: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding.

Authors:  Jian Xie; Akinori Okano; Joshua G Pierce; Robert C James; Simon Stamm; Christine M Crane; Dale L Boger
Journal:  J Am Chem Soc       Date:  2012-01-06       Impact factor: 15.419

4.  A redesigned vancomycin engineered for dual D-Ala-D-ala And D-Ala-D-Lac binding exhibits potent antimicrobial activity against vancomycin-resistant bacteria.

Authors:  Jian Xie; Joshua G Pierce; Robert C James; Akinori Okano; Dale L Boger
Journal:  J Am Chem Soc       Date:  2011-08-16       Impact factor: 15.419

Review 5.  Applications of Nonenzymatic Catalysts to the Alteration of Natural Products.

Authors:  Christopher R Shugrue; Scott J Miller
Journal:  Chem Rev       Date:  2017-06-05       Impact factor: 60.622

6.  Site-selective bromination of vancomycin.

Authors:  Tejas P Pathak; Scott J Miller
Journal:  J Am Chem Soc       Date:  2012-03-30       Impact factor: 15.419

7.  Probing the role of the vancomycin e-ring aryl chloride: selective divergent synthesis and evaluation of alternatively substituted E-ring analogues.

Authors:  Joseph R Pinchman; Dale L Boger
Journal:  J Med Chem       Date:  2013-05-13       Impact factor: 7.446

8.  Developments in Glycopeptide Antibiotics.

Authors:  Mark A T Blaskovich; Karl A Hansford; Mark S Butler; ZhiGuang Jia; Alan E Mark; Matthew A Cooper
Journal:  ACS Infect Dis       Date:  2018-02-19       Impact factor: 5.084

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.